FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024663025> ?p ?o ?g. }

• W2024663025 endingPage "e24032" @default.
• W2024663025 startingPage "e24032" @default.
• W2024663025 abstract "Inositol stereoisomers, myo- and scyllo-inositol, are known to enter the brain and are significantly elevated following oral administration. Elevations in brain inositol levels occur across a concentration gradient as a result of active transport from the periphery. There are two sodium/myo-inositol transporters (SMIT1, SMIT2) that may be responsible for regulating brain inositol levels. The goals of this study were to determine the effects of aging and Alzheimer's disease (AD)-like amyloid pathology on transporter expression, to compare regional expression and to analyze substrate requirements of the inositol transporters. QPCR was used to examine expression of the two transporters in the cortex, hippocampus and cerebellum of TgCRND8 mice, a mouse model of amyloid pathology, in comparison to non-transgenic littermates. In addition, we examined the structural features of inositol required for active transport, utilizing a cell-based competitive uptake assay. Disease pathology did not alter transporter expression in the cortex or hippocampus (p>0.005), with only minimal effects of aging observed in the cerebellum (SMIT1: F(2,26) = 12.62; p = 0.0002; SMIT2: F(2,26) = 8.71; p = 0.0015). Overall, brain SMIT1 levels were higher than SMIT2, however, regional differences were observed. For SMIT1, at 4 and 6 months cerebellar SMIT1 levels were significantly higher than cortical and hippocampal levels (p<0.05). For SMIT2, at all three ages both cortical and cerebellar SMIT2 levels were significantly higher than hippocampal levels (p<0.05) and at 4 and 6 months of age, cerebellar SMIT2 levels were also significantly higher than cortical levels (p<0.05). Inositol transporter levels are stably expressed as a function of age, and expression is unaltered with disease pathology in the TgCRND8 mouse. Given the fact that scyllo-inositol is currently in clinical trials for the treatment of AD, the stable expression of inositol transporters regardless of disease pathology is an important finding." @default.
• W2024663025 created "2016-06-24" @default.
• W2024663025 creator A5014013622 @default.
• W2024663025 creator A5040529254 @default.
• W2024663025 creator A5056395849 @default.
• W2024663025 creator A5061884695 @default.
• W2024663025 creator A5087103900 @default.
• W2024663025 date "2011-08-26" @default.
• W2024663025 modified "2023-09-26" @default.
• W2024663025 title "Sodium/myo-Inositol Transporters: Substrate Transport Requirements and Regional Brain Expression in the TgCRND8 Mouse Model of Amyloid Pathology" @default.
• W2024663025 cites W1502315999 @default.
• W2024663025 cites W1568192877 @default.
• W2024663025 cites W1587432965 @default.
• W2024663025 cites W1600695922 @default.
• W2024663025 cites W1967823816 @default.
• W2024663025 cites W1983199457 @default.
• W2024663025 cites W1985103555 @default.
• W2024663025 cites W2001142544 @default.
• W2024663025 cites W2002655900 @default.
• W2024663025 cites W2009048091 @default.
• W2024663025 cites W2046446546 @default.
• W2024663025 cites W2051728893 @default.
• W2024663025 cites W2056544109 @default.
• W2024663025 cites W2057109662 @default.
• W2024663025 cites W2059406369 @default.
• W2024663025 cites W2068836668 @default.
• W2024663025 cites W2071505467 @default.
• W2024663025 cites W2085560767 @default.
• W2024663025 cites W2089939887 @default.
• W2024663025 cites W2110127492 @default.
• W2024663025 cites W2126348672 @default.
• W2024663025 cites W2132693290 @default.
• W2024663025 cites W2140218592 @default.
• W2024663025 cites W2145398673 @default.
• W2024663025 cites W2151133389 @default.
• W2024663025 cites W2153747061 @default.
• W2024663025 doi "https://doi.org/10.1371/journal.pone.0024032" @default.
• W2024663025 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3162603" @default.
• W2024663025 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21887366" @default.
• W2024663025 hasPublicationYear "2011" @default.
• W2024663025 type Work @default.
• W2024663025 sameAs 2024663025 @default.
• W2024663025 citedByCount "33" @default.
• W2024663025 countsByYear W20246630252012 @default.
• W2024663025 countsByYear W20246630252013 @default.
• W2024663025 countsByYear W20246630252014 @default.
• W2024663025 countsByYear W20246630252015 @default.
• W2024663025 countsByYear W20246630252016 @default.
• W2024663025 countsByYear W20246630252017 @default.
• W2024663025 countsByYear W20246630252018 @default.
• W2024663025 countsByYear W20246630252019 @default.
• W2024663025 countsByYear W20246630252020 @default.
• W2024663025 countsByYear W20246630252021 @default.
• W2024663025 countsByYear W20246630252022 @default.
• W2024663025 countsByYear W20246630252023 @default.
• W2024663025 crossrefType "journal-article" @default.
• W2024663025 hasAuthorship W2024663025A5014013622 @default.
• W2024663025 hasAuthorship W2024663025A5040529254 @default.
• W2024663025 hasAuthorship W2024663025A5056395849 @default.
• W2024663025 hasAuthorship W2024663025A5061884695 @default.
• W2024663025 hasAuthorship W2024663025A5087103900 @default.
• W2024663025 hasBestOaLocation W20246630251 @default.
• W2024663025 hasConcept C102230213 @default.
• W2024663025 hasConcept C104317684 @default.
• W2024663025 hasConcept C126322002 @default.
• W2024663025 hasConcept C134018914 @default.
• W2024663025 hasConcept C141035611 @default.
• W2024663025 hasConcept C148762608 @default.
• W2024663025 hasConcept C149011108 @default.
• W2024663025 hasConcept C169760540 @default.
• W2024663025 hasConcept C170493617 @default.
• W2024663025 hasConcept C185592680 @default.
• W2024663025 hasConcept C2777348757 @default.
• W2024663025 hasConcept C2777427919 @default.
• W2024663025 hasConcept C2779134260 @default.
• W2024663025 hasConcept C2779652256 @default.
• W2024663025 hasConcept C2781161787 @default.
• W2024663025 hasConcept C502032728 @default.
• W2024663025 hasConcept C55493867 @default.
• W2024663025 hasConcept C71924100 @default.
• W2024663025 hasConcept C86803240 @default.
• W2024663025 hasConceptScore W2024663025C102230213 @default.
• W2024663025 hasConceptScore W2024663025C104317684 @default.
• W2024663025 hasConceptScore W2024663025C126322002 @default.
• W2024663025 hasConceptScore W2024663025C134018914 @default.
• W2024663025 hasConceptScore W2024663025C141035611 @default.
• W2024663025 hasConceptScore W2024663025C148762608 @default.
• W2024663025 hasConceptScore W2024663025C149011108 @default.
• W2024663025 hasConceptScore W2024663025C169760540 @default.
• W2024663025 hasConceptScore W2024663025C170493617 @default.
• W2024663025 hasConceptScore W2024663025C185592680 @default.
• W2024663025 hasConceptScore W2024663025C2777348757 @default.
• W2024663025 hasConceptScore W2024663025C2777427919 @default.
• W2024663025 hasConceptScore W2024663025C2779134260 @default.
• W2024663025 hasConceptScore W2024663025C2779652256 @default.
• W2024663025 hasConceptScore W2024663025C2781161787 @default.
• W2024663025 hasConceptScore W2024663025C502032728 @default.
• W2024663025 hasConceptScore W2024663025C55493867 @default.

• next